Skip to content

Opioid Dependence

Opioid dependence develops when the brain adapts to repeated exposure to opioids, including heroin, opioid painkillers, or synthetic opioids, and can no longer regulate mood, pain, and motivation without them. It is recognised as a chronic medical condition, not a failure of willpower. Stopping abruptly triggers withdrawal: sweating, cramps, agitation, and intense cravings that make unassisted recovery extremely difficult.

Revia

Naltrexone

50mg

Naltrexone 50mg film-coated tablets, used in the management of alcohol dependence and opioid dependence. A competitive opioid receptor antagonist.

From$4.45/ tabletView

Key points

  • The brain rewires itself after sustained opioid use, losing its capacity to manage mood, pain relief and drive without the substance.
  • Sudden cessation brings on withdrawal, sweating, cramping, restlessness and powerful urges that make quitting alone extremely hard.
  • After detoxification, naltrexone occupies opioid receptors so that taking an opioid afterwards produces no effect.
  • Pairing medicine with structured behavioural support tends to produce better results than relying on only one approach.

Blocking cravings to support recovery

Once a person has cleared opioids from their system, the main risk is relapse. Naltrexone works by blocking opioid receptors entirely, so that taking an opioid produces no reward. This makes it a useful maintenance tool for motivated individuals who have already completed detoxification. It is used alongside counselling and peer support rather than as a stand-alone fix. Full addiction recovery programmes combining medication with behavioural therapy consistently show better outcomes than either approach alone.

If you or someone you know is in crisis, contact a local mental health helpline or emergency service without delay.

Further reading